LATEST
Sanofi Announces First Acquisition Deal of 2024 to Strengthen Rare Disease Portfolio at $2.2 Billion
2024-01-24
New Technology and Nomenclature to Lead the Transformation of Fatty Liver Disease Diagnosis
2024-01-24
Biotech Showcase 2024: A Wave of Innovation Washes Over Healthcare’s Future (Oncology Sector)
2024-01-24
Arab Health 2024 Sells Out as International Exhibitors Hit Record Levels
2024-01-19Partner
Parexel and Japanese Foundation for Cancer Research Collaborate to Boost Oncology Clinical Trials in Japan
2024-01-18
Biotech and Pharma IPOs Surge with Innovative Therapies in the Beginning of 2024: From Kymera Therapeutics to Kyverna Therapeutics Lead the Way
2024-01-18
Neurolief’s Neuromodulation Device Receives Japanese Approval for At-Home Migraine Treatment
2024-01-16